Vertex Pharmaceuticals Emails and Email Format
Our service has identified one main email format for the Vertex Pharmaceuticals:
{first_name}_{last_name}@vrtx.com — 64.3% (example: [email protected])
{first_name}.{last_name}@vrtx.com — 35.7% (example: [email protected])
Contact details of Vertex Pharmaceuticals employees
Thomas Carney: Manager (GMP facility focus), Project Management Office, Global Capital Project Management - t***********[email protected]
Gillian: Vice President, Strategic Operations, Regulatory Affairs and Quality - [email protected]
Reshma Kewalramani: CEO and President - r****************[email protected]
Javier Coindreau: VP Global Strategy Lead - Medical Affairs - j**************[email protected]
Uma Raut: Director Global Regulatory Affairs, Cell and Gene Therapy - u******[email protected]
Michele Bellandi: Vice President International Commercial - m**************[email protected]
Elena Minichiello: Associate Director, Market Access Strategy and Planning - e***************[email protected]
Rabah Chibane: Operations Supervisor - r***********[email protected]
Robin Bean: Site Activation Manager - r********[email protected]
Joshua Chen: VP Biostatistics - j*[email protected]
Mark Yu: Senior Research Associate - m*****[email protected]
Isaac Vasanthkumar - i****************[email protected]
Guoxiang Ruan - g***********[email protected]
Phillip Snyder - p************[email protected]
Mac Johnson: Senior Director, Research, Vertex Pharmaceuticals - m*********[email protected]
Morrey Atkinson - m*************[email protected]
Other Vertex Pharmaceuticals Emails
Key indicators of the Vertex Pharmaceuticals
HQ: Boston, Massachusetts, United States
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 1, 2024
Domain: vrtx.com
Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.